Vanta Bioscience Share Price
20.58+0.00 (+0.00%)
-16.44% past 1 Year
Corporate filings & documents
Announcements
Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026
2 weeks agoOutcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026
2 weeks agoAudited standalone and consolidated Financial Results for the half year and financial year ended March 31 2026
3 months agoOutcome of the Board Meeting held on 30.05.2026
3 months agoOutcome of the Board Meeting held on 30.05.2026
3 months agoVanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon
3 months agoVanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon
3 months agoCertificate under Reg. 74(5) of SEBI(DP) Regulations 2018
5 months agoCertificate under Reg. 74(5) of SEBI(DP) Regulations 2018
5 months agoClosure of Trading Window
6 months agoClarification on Movement in Price
6 months agoClarification on Movement in Price
6 months agoThe Exchange has sought clarification from Vanta Bioscience Ltd on February 25 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
6 months agoOutcome of the Board Meeting - Appointment of Company Secretary and Compliance Officer
7 months agoFinancial results for the half year ended September 30 2025
10 months agoOutcome of the Board Meeting held on November 14 2025
10 months agoVanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Unaudited financial results of the Company for the half year ended September 30 2025 and to take note of the limited review report of the statutory auditors thereon.
10 months agoResignation of Company Secretary & Compliance Officer w.e.f 01.11.2025
10 months agoAnnual Report for FY 2024-25
10 months agoVoting Results and Scrutinizers Report
11 months agoProceedings of 9th Annual General Meeting of the Company
11 months agoIntimation of Closure of Trading Window
11 months agoAnnual reports
Concalls & investor presentations
No presentations found